Anteris Technologies Global Corp. (NASDAQ:AVR – Get Free Report) major shareholder L1 Capital Pty Ltd sold 475,693 shares of the stock in a transaction dated Monday, August 3rd. The stock was sold at an average price of $8.10, for a total transaction of $3,853,113.30. Following the transaction, the insider directly owned 6,108,910 shares of the company’s stock, valued at approximately $49,482,171. This trade represents a 7.22% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Large shareholders that own 10% or more of a company’s stock are required to disclose their transactions with the SEC.
L1 Capital Pty Ltd also recently made the following trade(s):
- On Friday, July 31st, L1 Capital Pty Ltd sold 48,711 shares of Anteris Technologies Global stock. The shares were sold at an average price of $8.15, for a total transaction of $396,994.65.
- On Wednesday, July 29th, L1 Capital Pty Ltd sold 155,505 shares of Anteris Technologies Global stock. The shares were sold at an average price of $8.04, for a total transaction of $1,250,260.20.
- On Thursday, July 30th, L1 Capital Pty Ltd sold 558,633 shares of Anteris Technologies Global stock. The shares were sold at an average price of $8.20, for a total transaction of $4,580,790.60.
- On Monday, July 27th, L1 Capital Pty Ltd sold 232,817 shares of Anteris Technologies Global stock. The stock was sold at an average price of $8.19, for a total transaction of $1,906,771.23.
- On Tuesday, July 28th, L1 Capital Pty Ltd sold 208,731 shares of Anteris Technologies Global stock. The stock was sold at an average price of $8.09, for a total transaction of $1,688,633.79.
- On Friday, July 24th, L1 Capital Pty Ltd sold 23,000 shares of Anteris Technologies Global stock. The stock was sold at an average price of $8.13, for a total transaction of $186,990.00.
Anteris Technologies Global Stock Performance
Anteris Technologies Global stock opened at $8.28 on Tuesday. Anteris Technologies Global Corp. has a fifty-two week low of $3.09 and a fifty-two week high of $11.06. The firm has a 50 day moving average price of $9.19 and a 200 day moving average price of $7.19. The company has a market capitalization of $805.99 million, a PE ratio of -3.71 and a beta of 1.65.
Institutional Investors Weigh In On Anteris Technologies Global
Several large investors have recently bought and sold shares of AVR. Russell Investments Group Ltd. raised its position in Anteris Technologies Global by 76.9% in the 3rd quarter. Russell Investments Group Ltd. now owns 6,536 shares of the company’s stock valued at $29,000 after purchasing an additional 2,841 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. purchased a new position in shares of Anteris Technologies Global in the 1st quarter valued at about $32,000. BNP Paribas Financial Markets grew its position in shares of Anteris Technologies Global by 83.3% during the third quarter. BNP Paribas Financial Markets now owns 9,469 shares of the company’s stock worth $43,000 after buying an additional 4,302 shares in the last quarter. Bank of America Corp DE grew its position in shares of Anteris Technologies Global by 35.7% during the third quarter. Bank of America Corp DE now owns 10,631 shares of the company’s stock worth $48,000 after buying an additional 2,798 shares in the last quarter. Finally, Duncan Williams Asset Management LLC purchased a new stake in shares of Anteris Technologies Global during the fourth quarter worth approximately $54,000.
Analyst Ratings Changes
Several research firms recently issued reports on AVR. Wall Street Zen upgraded Anteris Technologies Global from a “sell” rating to a “hold” rating in a report on Saturday, May 16th. Barclays raised their target price on Anteris Technologies Global from $17.00 to $18.00 and gave the company an “overweight” rating in a report on Friday, May 15th. Finally, Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Anteris Technologies Global in a research report on Friday, May 29th. Four investment analysts have rated the stock with a Buy rating and one has given a Sell rating to the company. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $16.00.
View Our Latest Analysis on Anteris Technologies Global
Anteris Technologies Global Company Profile
Anteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.
Further Reading
- Five stocks we like better than Anteris Technologies Global
- SpaceX’s First Earnings Report Could Decide Whether Shorts or Bulls Have Control
- Why Rare Earth Processing Could Be the Real 2027 Opportunity
- The S&P 493 Are Staging a Comeback—This Value ETF Offers Broad Exposure
- TSMC Insiders Are Buying the Pullback—But Is the Signal as Bullish as It Looks?
Receive News & Ratings for Anteris Technologies Global Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anteris Technologies Global and related companies with MarketBeat.com's FREE daily email newsletter.
